Art therapy during chemo: mandala painting may ease fear and pain in young cancer patients
NCT ID NCT07363005
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a parent-child mandala painting activity during chemotherapy could reduce fear and pain in children with cancer and ease the burden on their caregivers. 108 children aged 5-12 and their parents took part, with half doing six 30-minute painting sessions over two weeks. The goal was to see if this creative, non-drug approach could improve emotional well-being during a tough treatment process.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- parent-child mandala painting sessions
- What this could lead to
- If it works, this could offer a simple, drug-free way to help children feel less fear and pain during chemotherapy and support their parents' emotional well-being.
- What could go wrong
- This is a small, completed trial with 108 participants, so results may not apply to all children. The effect may be modest and not replace standard medical care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
108 people
The number who actually took part.
- Started
-
Nov 2025
- Finished
-
Mar 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
5 to 12 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children aged between 5 and 12 years who are receiving chemotherapy. * One parent or primary caregiver willing to participate with the child. * Ability of the child to perform basic fine motor activities such as holding a pencil and coloring. * Absence of an acute psychiatric diagnosis in the child (e.g., severe anxiety disorder, psychotic disorders). * Willingness of both the child and the parent to participate in the study. Exclusion Criteria: * Children diagnosed with stage III or stage IV cancer. * Presence of visual perception impairments in the child (e.g., color blindness, severe visual impairment). * Refusal of the child or parent to participate in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Childhood cancers are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Van Yuzuncu Yil University Dursun Odabas Medical Center
Van, Turkey, 65090, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Exercise as medicine: a new weapon in the fight against childhood cancer?
- Robot buddy may calm kids during scary cancer treatment
- Taste and smell tests for kids with cancer: a feasibility study
- Robot dog brings joy to kids battling blood cancer
- Puppets and squeeze toys may ease IV fear for young cancer patients
- Mindfulness may ease 'Scanxiety' for parents of kids with cancer